Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Indolent Non-hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00060684
What this trial is testing

Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Low-GradeLymphoma, Small LymphocyticLymphoma, Mixed-Cell, Follicular+1 more
CTI BioPharma 30
Not applicableWithdrawnNCT02762448
What this trial is testing

Interferon-free Antiviral Treatment of HCV-Positive Genotype 1b Related Indolent Non-Hodgkin Lymphomas

Who this might be right for
Hepatitis c
Tainan Municipal Hospital
Not applicableStudy completedNCT00461084
What this trial is testing

Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 36
Early research (Phase 1)Active Not RecruitingNCT04447716
What this trial is testing

An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Follicular LymphomaRecurrent Indolent Adult Non-Hodgkin Lymphoma+5 more
Thomas Jefferson University 4
Large-scale testing (Phase 3)Study completedNCT02369016
What this trial is testing

Phase III Copanlisib in Rituximab-refractory iNHL

Who this might be right for
Lymphoma, Non-Hodgkin
Bayer 25
Testing effectiveness (Phase 2)Looking for participantsNCT06350318
What this trial is testing

Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

Who this might be right for
Follicular LymphomaMarginal Zone LymphomaB-Cell Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 43
Large-scale testing (Phase 3)Study completedNCT01500083
What this trial is testing

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Indolent Non-Hodgkin's LymphomaChronic Lymphocytic Leukemia
Lundbeck Canada Inc. 90
Testing effectiveness (Phase 2)Study completedNCT03711578
What this trial is testing

Efficacy and Safety Study of Tenalisib (RP6530), a Novel PI3K δ/γ Dual Inhibitor in Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (iNHL)

Who this might be right for
Non Hodgkin Lymphoma
Rhizen Pharmaceuticals SA 20
Testing effectiveness (Phase 2)Study completedNCT00695786
What this trial is testing

Lenalidomide in Combination With Rituximab in Treating Participants With Stage III/IV Indolent Non-Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage III Grade 1 Follicular LymphomaAnn Arbor Stage III Grade 2 Follicular LymphomaAnn Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma+7 more
M.D. Anderson Cancer Center 156
Early research (Phase 1)WithdrawnNCT04635683
What this trial is testing

Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueRecurrent Follicular Lymphoma+21 more
Yazeed Sawalha
Very early researchEnded earlyNCT03585725
What this trial is testing

A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma

Who this might be right for
Follicular LymphomaMantle Cell Lymphoma
Weill Medical College of Cornell University 3
Testing effectiveness (Phase 2)Looking for participantsNCT07285590
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma (MCL)
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 50
Large-scale testing (Phase 3)Looking for participantsNCT06091254
What this trial is testing

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
Regeneron Pharmaceuticals 822
Testing effectiveness (Phase 2)Study completedNCT00240565
What this trial is testing

Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 93
Early research (Phase 1)Study completedNCT00001512
What this trial is testing

Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

Who this might be right for
B Cell LymphomaFollicular LymphomaLymphoma
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT03492775
What this trial is testing

First Line Therapy of Advanced Stage Follicular Lymphoma in Patients < 60 Years Not Eligible fo Standard Immunochemotherapy and in All Patients ≥ 60 Years

Who this might be right for
Indolent Non-hodgkin Lymphoma
Prof. Dr. Wolfgang Hiddemann 46
Testing effectiveness (Phase 2)WithdrawnNCT00003663
What this trial is testing

Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Hoag Memorial Hospital Presbyterian
Testing effectiveness (Phase 2)Study completedNCT00220285
What this trial is testing

Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaLymphoma, B-CellLymphoma, Low-Grade
Bayer 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT03198026
What this trial is testing

Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas

Who this might be right for
Non-Hodgkin's LymphomaAnn Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueAnn Arbor Stage II Follicular Lymphoma+16 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 29
Early research (Phase 1)Study completedNCT01705847
What this trial is testing

A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies

Who this might be right for
Lymphoid Malignancies
Gilead Sciences 39
Next Page